|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardioprotection by resveratrol:a human clinical trial in patients with stablecoronary artery disease 显示文摘 | Magyar K Halmosi R Palfi A | 2012 | Clin Hemorheol Microcirc2012，50，3： | 1 |
| 2 | Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound 显示文摘 | Deres P Halmosi R Toth A | 2005 | J Cardiovasc Pharmacol2005，45，1： | 1 |
| 3 | In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine 显示文摘 | E Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 4 | Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound显示文摘 | Halmosi R Toth A | 2005 | J Cardiovasc Pharmacol2005，45，： | 1 |
| 5 | Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease 显示文摘 | Magyar K Halmosi R Palfi A | 2012 | Clin Hemorheol Microcire2012，50，3： | 1 |
| 6 | Prevention of doxorubicin- induced acute cardiotoxicity by an experimental antioxidant compound显示文摘 | Deres P Halmosi R Toth A | 2005 | J Cardiovasc Pharmaco12005，45，1： | 1 |
| 7 | In vitro antioxidantproperties ofpentoxifylline,piraeetam,and vinpocetine显示文摘 | Horvath B Marton Z Halmosi R | | 0，，01： | 1 |
| 8 | In vitro antioxidant properties of pentoxifylline,piracetam,and vinpocetine显示文摘 | Horvath B Marton Z Halmosi R | | 0，，01： | 1 |
| 9 | Cardiopmtection by res- veratrol : a human clinical trial in patients with stable coronary ar- tery disease 显示文摘 | Magyar K Halmosi R Palfi A | 2012 | Clin Hemorheol Micmcirc2012，50，3： | 1 |
| 10 | In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine 显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharma- col2002，25，1： | 1 |
| 11 | Prevention of doxorubicin induced acute cardiotoxicity by an experimental antioxidant compound显示文摘 | Deres P Halmosi R Toth A | | 0，，01： | 1 |
| 12 | Prevention of doxorubi-cin-induced acute cardiotoxicity by an experimental antioxidantcompound显示文摘 | DERES P HALMOSI R TOTH A | 2005 | J Cardiovasc Pharmacol2005，45，1： | 1 |
| 13 | Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound显示文摘 | Deres P Halmosi R Toth A | 2005 | J Cardiovasc Pharmacol2005，45，1： | 1 |
| 14 | Prevention of doxorubicin-induced acute cardio toxicity by an experimental antioxidant com-pound显示文摘 | Deres P Halmosi R Toth A | 2005 | J Cardiovasc Pharmacol2005，45，1： | 1 |
| 15 | In vitro antioxidant properties of pentoxifylline, piracentam and vincamine显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 16 | In vitro antioxi- dant properties of pentoxifylline, piraeentam and vcamine 显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 17 | In vitro antioxidant properties of pentoxifylline,piracetam,and vinpocetine显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 18 | In vitro antioxidant properties of pentoxifylline, piracetam and vinpocentine显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 19 | ln vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine显示文摘 | Horvath B Marton Z Halmosi R | 2002 | Clin Neuropharmacol2002，25，1： | 1 |
| 20 | Prevention of doxorubieininduced acute cardiotoxicity by an experimental antioxidant compound显示文摘 | Deres P Halmosi R Toth A | 2005 | J Cardiovasc Pharmaco12005，45，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员